NCT01022918View on ClinicalTrials.gov

Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma

PHASE2CompletedINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

January 31, 2011

Conditions

Naive Unresectable Glioblastoma

Interventions

DRUG

Avastin + Campto / radiotherapy + Temodal + Avastin (4 cures)

DRUG

Temodal/radiotherapy

Trial Locations (1)

21000

Centre Georges François Leclerc, Dijon

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

National Cancer Institute, France

OTHER_GOV

collaborator

Association de Neuro-Oncologues d'Expression Francaise

OTHER

collaborator

UNICANCER

OTHER

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

Centre Georges Francois Leclerc

OTHER